Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.
about
Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1Tangible resources for preparing patients for antiviral therapy for chronic hepatitis CEpidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?Dickkopfs and Wnt/β-catenin signalling in liver cancerImpact of rural residence and health system structure on quality of liver careBile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinomaUse of administrative claims data for identifying patients with cirrhosisAn automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission.Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.Hepatitis C virus screening in patients with cancer receiving chemotherapy.Factors influencing adherence in Hepatitis-C infected patients: a systematic reviewSofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States.Hepatitis C Virus and Liver Transplantation.Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.Fibrosis-dependent mechanisms of hepatocarcinogenesisLiver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China.Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus.Hospitalization for variceal hemorrhage in an era with more prevalent cirrhosis.Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma.Current and Future Burden of Chronic Nonmalignant Liver DiseaseProactive case finding to improve concurrently curative and palliative care in patients with end-stage liver disease.Impact of physician specialty on quality care for patients hospitalized with decompensated cirrhosis.Gender differences in planning ability and hepatitis C virus among people who inject drugs.Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.MicroRNAs: Role in Hepatitis C Virus pathogenesisNovel insights into the function and dynamics of extracellular matrix in liver fibrosis.Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance.Accuracy of ultrasound and noninvasive markers of fibrosis to identify patients with cirrhosisProportions of acetyl-histone-positive hepatocytes indicate the functional status and prognosis of cirrhotic patientsHepatitis C virus infection: establishment of chronicity and liver disease progressionA pathological fracture and a solitary mass in the right clavicle: an unusual first presentation of HCC and the role of immunohistochemistryElastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma.Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease.Risk of liver cancer among US male veterans with cirrhosis, 1969-1996Cost-effectiveness and population outcomes of general population screening for hepatitis C.miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma.Chronic hepatitis C in saudi arabia: three years local experience in a university hospital.Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis PatientsEffect of obstructive sleep apnea on the sleep architecture in cirrhosis.
P2860
Q26768128-D22B1C6D-473B-420F-A429-4F2092DF203FQ26858962-BCC45846-D248-4303-B8DA-CF60402E9C66Q27025083-AF891451-503E-430E-B098-B95C6D350CB8Q28391394-0B2F7235-2502-41A6-82B6-A85B028C1150Q28538020-0D28D83F-DF6D-4CE2-96F9-FCE8C82665C8Q30414018-80658175-6DDD-4528-B82F-71A590DC1154Q30574442-EB53787E-075A-491C-8DEA-D5F403225C47Q30617374-695162D4-804D-427A-9163-3418884FB64EQ30841159-FA656E36-9342-4909-BC3F-20CAE0D5EF07Q33600085-A8D9BF4C-6866-4BE7-AED0-446E9CD088F1Q33612472-FEB3DDA0-EC72-49D4-95D7-C5A40570B35CQ33621614-BC451316-2A5A-479C-B6A8-57CB4655E573Q33717116-CE57B3D3-16BD-4842-98EA-CA671181DE9EQ33780136-AA24F1CC-8444-40A5-8B7C-7B6219CD5BA8Q33865082-272F3ED8-4028-4BE4-A2E5-6500572566B4Q33879949-6D298A13-69F4-4A2E-BB9D-DFCDDA63FCF0Q33904328-09D91D48-6E83-4E57-B5C5-D1EEC2D65309Q33922932-503EC51D-8974-46F7-A598-F9E2314A2159Q34093871-8C1416B9-C8CF-47E0-9475-DA8299639F5AQ34461237-9046DBD4-6D43-4140-9F55-31A3C7A13DA8Q34490300-5596D9A3-9ED5-4518-973A-819BD4EABAB5Q35200244-3A29899A-9576-4221-B753-8823707D03D0Q35250184-F0408C50-F82B-4233-B8B8-849BE031BB17Q35562840-0EBC71EC-6A2C-4331-ABFE-494E8BF3EA25Q35590195-2C7D8B96-FE5B-4497-96BE-99DCD12FCE15Q35606627-DB17B61B-D02A-45B4-BBAE-461477457CCBQ35622533-A9904DC8-9F4C-4CDD-BD8D-2802AEE02EB8Q35650866-3A2F2276-2B0B-4850-9131-621E1B861AC2Q35685126-808FD0D7-B625-4B3B-9141-E710324D1619Q35692323-542B4949-30BB-48EF-B5A1-493F4C6EA1F0Q35728873-81A0FC50-14E6-4FB3-B590-2D5179B4C934Q35847791-25B3C3EF-F725-4C4E-A659-A5CF04DF5143Q36003201-149C3B92-E1C2-448E-844E-F9D3A9CFE5AAQ36006326-3772A597-C71D-4FDC-85EA-927EC34D062FQ36075198-02C18F6B-A04C-4ECE-A9BD-76DA8CD5329DQ36115516-E44E43AF-1E92-43C9-ADA5-825FF3729E6AQ36143130-A23453B6-B991-49B7-820F-E3AE7A6D56ACQ36329009-6D0AD97D-4C95-4A8B-9DF4-C7579C6119C0Q36412906-6878C837-8D8C-4CDC-9A4F-ADAD746F610CQ36627779-05F98F54-4F46-475A-89E6-644D72B871B7
P2860
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@ast
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@en
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@nl
type
label
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@ast
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@en
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@nl
prefLabel
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@ast
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@en
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@nl
P2093
P2860
P1433
P1476
Increasing prevalence of HCC a ...... c hepatitis C virus infection.
@en
P2093
Angelique Zeringue
Fasiha Kanwal
Hashem B El-Serag
Jennifer R Kramer
Matthew Bidwell Goetz
Peter Richardson
Steven M Asch
Tuyen Hoang
P2860
P304
1182-1188.e1
P356
10.1053/J.GASTRO.2010.12.032
P407
P577
2010-12-22T00:00:00Z